These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 11704834

  • 1. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
    Gilmore TD, Cormier C, Jean-Jacques J, Gapuzan ME.
    Oncogene; 2001 Oct 25; 20(48):7098-103. PubMed ID: 11704834
    [Abstract] [Full Text] [Related]

  • 2. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.
    Starczynowski DT, Reynolds JG, Gilmore TD.
    Oncogene; 2005 Nov 10; 24(49):7355-68. PubMed ID: 16027730
    [Abstract] [Full Text] [Related]

  • 3. Characterization of a human REL-estrogen receptor fusion protein with a reverse conditional transforming activity in chicken spleen cells.
    Kalaitzidis D, Ok J, Sulak L, Starczynowski DT, Gilmore TD.
    Oncogene; 2004 Sep 30; 23(45):7580-7. PubMed ID: 15326488
    [Abstract] [Full Text] [Related]

  • 4. Divergent C-terminal transactivation domains of Rel/NF-kappa B proteins are critical determinants of their oncogenic potential in lymphocytes.
    Fan Y, Rayet B, Gélinas C.
    Oncogene; 2004 Feb 05; 23(5):1030-42. PubMed ID: 14647412
    [Abstract] [Full Text] [Related]

  • 5. The c-Rel transcription factor and B-cell proliferation: a deal with the devil.
    Gilmore TD, Kalaitzidis D, Liang MC, Starczynowski DT.
    Oncogene; 2004 Mar 25; 23(13):2275-86. PubMed ID: 14755244
    [Abstract] [Full Text] [Related]

  • 6. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D, Rizzo CA, Dorfman K, Bravo R.
    EMBO J; 1996 Jul 15; 15(14):3640-50. PubMed ID: 8670867
    [Abstract] [Full Text] [Related]

  • 7. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
    Shehata M, Shehata M, Shehata F, Pater A.
    Cell Biol Int; 2004 Jul 15; 28(12):895-904. PubMed ID: 15566959
    [Abstract] [Full Text] [Related]

  • 8. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
    Chen X, Kandasamy K, Srivastava RK.
    Cancer Res; 2003 Mar 01; 63(5):1059-66. PubMed ID: 12615723
    [Abstract] [Full Text] [Related]

  • 9. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
    Starczynowski DT, Trautmann H, Pott C, Harder L, Arnold N, Africa JA, Leeman JR, Siebert R, Gilmore TD.
    Oncogene; 2007 Apr 26; 26(19):2685-94. PubMed ID: 17072339
    [Abstract] [Full Text] [Related]

  • 10. An optimal range of transcription potency is necessary for efficient cell transformation by c-Rel to ensure optimal nuclear localization and gene-specific activation.
    Fan Y, Gélinas C.
    Oncogene; 2007 Jun 07; 26(27):4038-43. PubMed ID: 17173064
    [Abstract] [Full Text] [Related]

  • 11. Identification of v-Rel oncogene-induced inhibitor of apoptosis by differential display.
    You M, Bose HR.
    Methods; 1998 Dec 07; 16(4):373-85. PubMed ID: 10049645
    [Abstract] [Full Text] [Related]

  • 12. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins.
    White DW, Gilmore TD.
    Oncogene; 1996 Sep 05; 13(5):891-9. PubMed ID: 8806678
    [Abstract] [Full Text] [Related]

  • 13. Aberrant rel/nfkb genes and activity in human cancer.
    Rayet B, Gélinas C.
    Oncogene; 1999 Nov 22; 18(49):6938-47. PubMed ID: 10602468
    [Abstract] [Full Text] [Related]

  • 14. [The Rel/NF-kappa B transcription factors and their biological functions].
    Kankova K, Vojtesek B, Valík D.
    Cas Lek Cesk; 2001 Mar 29; 140(6):163-7. PubMed ID: 11347205
    [Abstract] [Full Text] [Related]

  • 15. The nuclear factor kappaB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation.
    Hanson JL, Hawke NA, Kashatus D, Baldwin AS.
    Cancer Res; 2004 Oct 15; 64(20):7248-55. PubMed ID: 15492243
    [Abstract] [Full Text] [Related]

  • 16. Deletion of either C-terminal transactivation subdomain enhances the in vitro transforming activity of human transcription factor REL in chicken spleen cells.
    Starczynowski DT, Reynolds JG, Gilmore TD.
    Oncogene; 2003 Oct 09; 22(44):6928-36. PubMed ID: 14534540
    [Abstract] [Full Text] [Related]

  • 17. Methods for assessing the in vitro transforming activity of NF-κB transcription factor c-Rel and related proteins.
    Gilmore TD, Gélinas C.
    Methods Mol Biol; 2015 Oct 09; 1280():427-46. PubMed ID: 25736765
    [Abstract] [Full Text] [Related]

  • 18. v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNFalpha-induced cell death.
    Zong WX, Farrell M, Bash J, Gélinas C.
    Oncogene; 1997 Aug 18; 15(8):971-80. PubMed ID: 9285692
    [Abstract] [Full Text] [Related]

  • 19. NF-kappaB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival.
    Feng B, Cheng S, Hsia CY, King LB, Monroe JG, Liou HC.
    Cell Immunol; 2004 Aug 18; 232(1-2):9-20. PubMed ID: 15922711
    [Abstract] [Full Text] [Related]

  • 20. The v-Rel oncoprotein complexes with new Rel- and RelA-related proteins in transformed cells.
    Xu X, Gélinas C.
    Virology; 1995 Mar 10; 207(2):362-8. PubMed ID: 7886940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.